| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84331 |
cas:2055896-83-6,MC-Val-Cit-PAB-carfilzomib , ADC试剂 |
156 |
kx |
2024-12-19 |
| 84332 |
MAL-di-EG-Val-Cit-PAB-MMAF, ADC试剂 |
147 |
kx |
2024-12-19 |
| 84333 |
cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
174 |
zyl |
2024-12-19 |
| 84334 |
Hydrazone-doxorubicin, ADC试剂 |
294 |
kx |
2024-12-19 |
| 84335 |
DBCO-C4-Val-Cit-PABC-PNP |
160 |
zyl |
2024-12-19 |
| 84336 |
cas:644981-35-1 Val-Cit-PAB-MMAE |
152 |
zyl |
2024-12-19 |
| 84337 |
cas:170908-81-3,DOTA-NHS ester ,1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
136 |
kx |
2024-12-19 |
| 84338 |
endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 |
151 |
zyl |
2024-12-19 |
| 84339 |
cas:2259318-50-6,MA-PEG4-VA-PBD , ADC试剂 |
230 |
kx |
2024-12-19 |
| 84340 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
114 |
WYQ |
2024-12-19 |
| 84341 |
CAS: 2768446-73-5,DBCO-Val-Cit-PAB-MMAE |
146 |
WYQ |
2024-12-19 |
| 84342 |
MC-vc-PAB-C6-a-amanitin, ADC试剂 |
153 |
kx |
2024-12-19 |
| 84343 |
cas:663598-98-9,2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate,ADC定制 |
151 |
wyh |
2024-12-19 |
| 84344 |
cas:2873452-49-2 MC-EVCit-PAB-MMAE |
154 |
zyl |
2024-12-19 |
| 84345 |
2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate,ADC定制 |
175 |
wyh |
2024-12-19 |
| 84346 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin |
174 |
zyl |
2024-12-19 |
| 84347 |
Gly3-vc-PAB-MMAE, ADC试剂 |
195 |
kx |
2024-12-19 |
| 84348 |
CAS: 1869126-64-6, Azido-PEG4-Val-Cit-PAB-MMAE |
162 |
WYQ |
2024-12-19 |
| 84349 |
cas:2353409-54-6 , Mal-amido-PEG8-Val-Gly,ADC定制 |
183 |
wyh |
2024-12-19 |
| 84350 |
Azido-PEG4-Val-Ala-PAB-PNP |
185 |
zyl |
2024-12-19 |
| 84351 |
NOTA-(NGR)2 NOTA偶联NGR二聚体 |
143 |
h |
2024-12-19 |
| 84352 |
1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid,ADC定制 |
133 |
wyh |
2024-12-19 |
| 84353 |
CAS: 1343476-44-7,Val-Ala-PAB-OH |
137 |
WYQ |
2024-12-19 |
| 84354 |
MC-PBD, ADC试剂 |
166 |
kx |
2024-12-19 |
| 84355 |
Mal-Val-Ala-PAB的介绍 |
172 |
zyl |
2024-12-19 |
| 84356 |
DOTA-K-A9 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)结合肽A9 |
155 |
h |
2024-12-19 |
| 84357 |
Azide-PEG3-Val-Cit-PAB-MMAF,叠氮-三聚乙二醇-Val-Cit-PAB-MMAF |
148 |
WYQ |
2024-12-19 |
| 84358 |
Arm-DOTA-B72.3 |
153 |
h |
2024-12-19 |
| 84359 |
cas:1884577-99-4 Boc-Val-Ala-PAB |
163 |
zyl |
2024-12-19 |
| 84360 |
(Lys(DOTA)4)BVD15 DOTA偶联神经肽Y(NPY)类似物 |
240 |
h |
2024-12-19 |
| 84361 |
1801838-28-7,Mc-vc-PAB-SN38,化合物MC-VC-PAB-SN38 |
157 |
kx |
2024-12-19 |
| 84362 |
DOTA-PPI 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-官能化的聚(丙烯亚胺)(PPI)糖树枝状分子 |
158 |
h |
2024-12-19 |
| 84363 |
CAS: 863971-17-9,MC-Val-Cit-PAB-MMAF |
171 |
WYQ |
2024-12-19 |
| 84364 |
cas:1884577-99-4 Boc-Val-Ala-PAB |
199 |
zyl |
2024-12-19 |
| 84365 |
DBCO-PEG4-vc-PAB-MMAE, ADC试剂 |
194 |
kx |
2024-12-19 |
| 84366 |
1884578-00-0,Boc-PEG4-Val-Ala-PAB-PNP,ADC定制 |
182 |
wyh |
2024-12-19 |
| 84367 |
DOTA-Peg-Cpa-c[DCys-Aph(Cbm)-DTrp-Lys-Thr-Cys]-2Nal-NH2 |
151 |
h |
2024-12-19 |
| 84368 |
DOTA-2.5D DOTA-胱氨酸结肽(knottins)2.5D和2.5F |
190 |
h |
2024-12-19 |
| 84369 |
二苯并环辛炔-四聚乙二醇-VAL-ALA-PAB,ADC定制 |
173 |
wyh |
2024-12-19 |
| 84370 |
Hz220(DOTA-Lys(IR dye 650)-PEa(4)-[D-Phe(6)DOTA偶联的GRPr拮抗剂 |
167 |
h |
2024-12-19 |
| 84371 |
Azido-PEG4-MMAE,抗体药物偶联物(ADCs) |
190 |
WYQ |
2024-12-19 |
| 84372 |
1626359-62-3,SPDB-DM4, ADC试剂 |
142 |
kx |
2024-12-19 |
| 84373 |
Acid-PEG4-Val-Cit-PAB-MMAE,包含PEG链和MMAE等部分 |
174 |
WYQ |
2024-12-19 |
| 84374 |
cas:159857-70-2,MC-Val-Cit-Doxorubicin,ADC定制 |
164 |
wyh |
2024-12-19 |
| 84375 |
DOTA-(D)Phe(1)-Tyr(3) |
157 |
h |
2024-12-19 |